(Q35743185)

English

Cutting edge diagnostics in rheumatology: the role of patients, clinicians, and laboratory scientists in optimizing the use of autoimmune serology

scientific article published on April 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

1 reference

Europe PubMed Central

Cutting edge diagnostics in rheumatology: the role of patients, clinicians, and laboratory scientists in optimizing the use of autoimmune serology (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

1 reference

based on heuristic

inferred from title

Marvin J Fritzler

8

object named as

Marvin Fritzler

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Robert G. Lahita

4

object named as

Robert G Lahita

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

author name string

Allan S Wiik

1

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Thomas P Gordon

2

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Arthur F Kavanaugh

3

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Westley Reeves

5

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Walther J van Venrooij

6

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Merlin R Wilson

7

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

IUIS/WHO/AF/CDC Committee for the Standardization of Autoantibodies in Rheumatic and Related Diseases

9

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

publication date

1 April 2004

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Arthritis & Rheumatology

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

51

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

291-298

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop

1 reference

https://api.crossref.org/works/10.1002%2FART.20229

21 January 2018

Autoantibodies against small nucleolar ribonucleoprotein complexes and their clinical associations

1 reference

https://api.crossref.org/works/10.1002%2FART.20229

21 January 2018

Prevalence and clinical significance of antikeratin antibodies and other serological markers in Lithuanian patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.20229

21 January 2018

The immunologic homunculus in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.20229

21 January 2018

Serologically active clinically quiescent systemic lupus erythematosus: a discordance between clinical and serologic features

1 reference

https://api.crossref.org/works/10.1002%2FART.20229

21 January 2018

International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA)

1 reference

https://api.crossref.org/works/10.1002%2FART.20229

21 January 2018

Neutrophil-specific autoantibodies in chronic inflammatory bowel diseases

1 reference

https://api.crossref.org/works/10.1002%2FART.20229

21 January 2018

Multicenter evaluation study on a new HEp2 ANA screening enzyme immune assay

1 reference

https://api.crossref.org/works/10.1002%2FART.20229

21 January 2018

The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide

1 reference

https://api.crossref.org/works/10.1002%2FART.20229

21 January 2018

The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.20229

21 January 2018

When does rheumatoid arthritis begin and why do we need to know?

1 reference

https://api.crossref.org/works/10.1002%2FART.20229

21 January 2018

Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA)

1 reference

https://api.crossref.org/works/10.1002%2FART.20229

21 January 2018

An enzyme-linked immunosorbent assay for autoantibodies against the nuclear protein Scl-70

1 reference

https://api.crossref.org/works/10.1002%2FART.20229

21 January 2018

How to diagnose rheumatoid arthritis early: A prediction model for persistent (erosive) arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.20229

21 January 2018

Antineutrophil cytoplasmic antibodies in patients with early rheumatoid arthritis: an early marker of progressive erosive disease

1 reference

https://api.crossref.org/works/10.1002%2FART.20229

21 January 2018

Patterns of disease activity in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1002%2FART.20229

21 January 2018

False-positive myeloperoxidase binding activity due to DNA/anti-DNA antibody complexes: a source for analytical error in serologic evaluation of anti-neutrophil cytoplasmic autoantibodies

1 reference

https://api.crossref.org/works/10.1002%2FART.20229

21 January 2018

Reappraisal of the specificity of the Crithidia luciliae assay for nDNA antibodies: evidence for histone antibody kinetoplast binding

1 reference

https://api.crossref.org/works/10.1002%2FART.20229

21 January 2018

Specificity of autoantibodies to SS-A/Ro on a transfected and overexpressed human 60 kDa Ro autoantigen substrate

1 reference

https://api.crossref.org/works/10.1002%2FART.20229

21 January 2018

Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy

1 reference

https://api.crossref.org/works/10.1002%2FART.20229

21 January 2018

The association of anti-Ro52 autoantibodies with myositis and scleroderma autoantibodies

1 reference

https://api.crossref.org/works/10.1002%2FART.20229

21 January 2018

Disease spectrum of patients with antineutrophil cytoplasmic autoantibodies of defined specificity: distinct differences between patients with anti-proteinase 3 and anti-myeloperoxidase autoantibodies

1 reference

https://api.crossref.org/works/10.1002%2FART.20229

21 January 2018

Identifiers

10.1002/ART.20229

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35743185&oldid=1618044368"